terms |
rovelizumab |
As nouns the difference between terms and rovelizumab
is that
terms is while
rovelizumab is a humanized monoclonal antibody that was an experimental immunosuppressive drug intended to treat patients suffering from haemorrhagic shock by suppressing white blood cells.
haemorrhagic |
rovelizumab |
As an adjective haemorrhagic
is (chiefly|british).
As a noun rovelizumab is
a humanized monoclonal antibody that was an experimental immunosuppressive drug intended to treat patients suffering from haemorrhagic shock by suppressing white blood cells.
drug |
rovelizumab |
As nouns the difference between drug and rovelizumab
is that
drug is (pharmacology) a substance used to treat an illness, relieve a symptom, or modify a chemical process in the body for a specific purpose or
drug can be (obsolete) a drudge while
rovelizumab is a humanized monoclonal antibody that was an experimental immunosuppressive drug intended to treat patients suffering from haemorrhagic shock by suppressing white blood cells.
As a verb drug
is to administer intoxicating drugs to, generally without the recipient's knowledge or consent or
drug can be (
drag).
immunosuppressive |
rovelizumab |
As nouns the difference between immunosuppressive and rovelizumab
is that
immunosuppressive is (pharmacology) an agent which is capable of immunosuppression while
rovelizumab is a humanized monoclonal antibody that was an experimental immunosuppressive drug intended to treat patients suffering from haemorrhagic shock by suppressing white blood cells.
As an adjective immunosuppressive
is (pharmacology) having the capability to suppress the immune system, capable of immunosuppression.
experimental |
rovelizumab |
As an adjective experimental
is experimental.
As a noun rovelizumab is
a humanized monoclonal antibody that was an experimental immunosuppressive drug intended to treat patients suffering from haemorrhagic shock by suppressing white blood cells.
humanized |
rovelizumab |
As a verb humanized
is (
humanize).
As a noun rovelizumab is
a humanized monoclonal antibody that was an experimental immunosuppressive drug intended to treat patients suffering from haemorrhagic shock by suppressing white blood cells.